Normal Human Fibroblasts Are Resistant to RAS-Induced Senescence

REFERENCES

• Adams, J. M., and Cory S.. 1991. Transgenic models of tumor development. Science 254:1161–1167.
   PubMed Web of Science ®Google Scholar
• Bartz, S. R., and Vodicka M. A.. 1997. Production of high-titer human immunodeficiency virus type 1 pseudotyped with vesicular stomatitis virus glycoprotein. Methods 12:337–342.
   PubMedGoogle Scholar
• Benanti, J. A., Williams D. K., Robinson K. L., Ozer H. L., and Galloway D. A.. 2002. Induction of extracellular matrix-remodeling genes by the senescence-associated protein APA-1. Mol. Cell. Biol. 22:7385–7397.
   PubMedGoogle Scholar
• Bos, J. L. 1989. ras oncogenes in human cancer: a review. Cancer Res. 49:4682–4689.
   PubMed Web of Science ®Google Scholar
• Brookes, S., Rowe J., Ruas M., Llanos S., Clark P. A., Lomax M., James M. C., Vatcheva R., Bates S., Vousden K. H., Parry D., Gruis N., Smit N., Bergman W., and Peters G.. 2002. INK4a-deficient human diploid fibroblasts are resistant to RAS-induced senescence. EMBO J. 21:2936–2945.
   PubMed Web of Science ®Google Scholar
• Campisi, J., Dimri G., and Hara E.. 1996. Control of replicative senescence, p. 121–149. In Johnson T. E., Holbrook N. J., and Morrison J. H. (ed.), Handbook of the biology of aging. Academic Press, San Diego, Calif.
   Google Scholar
• Dimri, G. P., Lee X., Basile G., Acosta M., Scott G., Roskelley C., Medrano E. E., Linskens M., Rubelj I., Pereira-Smith O., Peacocke M., and Campisi J.. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92:9363–9367.
   PubMed Web of Science ®Google Scholar
• Downward, J. 2003. Targeting RAS signalling pathways in cancer therapy. Nat. Rev. Cancer 3:11–22.
   PubMed Web of Science ®Google Scholar
• Dyson, N. 1998. The regulation of E2F by pRB-family proteins. Genes Dev. 12:2245–2262.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Suarez, E., Samper E., Ramirez A., Flores J. M., Martin-Caballero J., Jorcano J. L., and Blasco M. A.. 2001. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J. 20:2619–2630.
   PubMed Web of Science ®Google Scholar
• Guerra, C., Mijimolle N., Dhawahir A., Dubus P., Barradas M., Serrano M., Campuzano V., and Barbacid M.. 2003. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 4:111–120.
   PubMed Web of Science ®Google Scholar
• Hahn, W. C., Dessain S. K., Brooks M. W., King J. E., Elenbaas B., Sabatini D. M., DeCaprio J. A., and Weinberg R. A.. 2002. Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol. Cell. Biol. 22:2111–2123.
   PubMed Web of Science ®Google Scholar
• Hengst, L., and Reed S. I.. 1998. Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227:25–41.
   PubMedGoogle Scholar
• Huot, T. J., Rowe J., Harland M., Drayton S., Brookes S., Gooptu C., Purkis P., Fried M., Bataille V., Hara E., Newton-Bishop J., and Peters G.. 2002. Biallelic mutations in p16INK4a confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol. Cell. Biol. 22:8135–8143.
   PubMed Web of Science ®Google Scholar
• Itahana, K., Zou Y., Itahana Y., Martinez J. L., Beausejour C., Jacobs J. J., van Lohuizen M., Band V., Campisi J., and Dimri G. P.. 2003. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1. Mol. Cell. Biol. 23:389–401.
   PubMed Web of Science ®Google Scholar
• Johnson, L., Mercer K., Greenbaum D., Bronson R. T., Crowley D., Tuveson D. A., and Jacks T.. 2001. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 410:1111–1116.
   PubMed Web of Science ®Google Scholar
• Jones, C. J., Kipling D., Morris M., Hepburn P., Skinner J., Bounacer A., Wyllie F. S., Ivan M., Bartek J., Wynford-Thomas D., and Bond J. A.. 2000. Evidence for a telomere-independent “clock” limiting RAS oncogene-driven proliferation of human thyroid epithelial cells. Mol. Cell. Biol. 20:5690–5699.
   PubMedGoogle Scholar
• Kamijo, T., Zindy F., Roussel M. F., Quelle D. E., Downing J. R., Ashmun R. A., Grosveld G., and Sherr C. J.. 1997. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91:649–659.
   PubMed Web of Science ®Google Scholar
• Kiyono, T., Foster S. A., Koop J. I., McDougall J. K., Galloway D. A., and Klingelhutz A. J.. 1998. Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 396:84–88.
   PubMed Web of Science ®Google Scholar
• Klaes, R., Benner A., Friedrich T., Ridder R., Herrington S., Jenkins D., Kurman R. J., Schmidt D., Stoler M., and von Knebel D. M.. 2002. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am. J. Surg. Pathol. 26:1389–1399.
   PubMed Web of Science ®Google Scholar
• Klaes, R., Friedrich T., Spitkovsky D., Ridder R., Rudy W., Petry U., Dallenbach-Hellweg G., Schmidt D., and von Knebel D. M.. 2001. Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int. J. Cancer 92:276–284.
   PubMed Web of Science ®Google Scholar
• Lee, A. C., Fenster B. E., Ito H., Takeda K., Bae N. S., Hirai T., Yu Z. X., Ferrans V. J., Howard B. H., and Finkel T.. 1999. Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species. J. Biol. Chem. 274:7936–7940.
   PubMed Web of Science ®Google Scholar
• Lin, A. W., Barradas M., Stone J. C., van Aelst L., Serrano M., and Lowe S. W.. 1998. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev. 12:3008–3019.
   PubMed Web of Science ®Google Scholar
• Lindvall, C., Hou M., Komurasaki T., Zheng C., Henriksson M., Sedivy J. M., Bjorkholm M., Teh B. T., Nordenskjold M., and Xu D.. 2003. Molecular characterization of human telomerase reverse transcriptase-immortalized human fibroblasts by gene expression profiling: activation of the epiregulin gene. Cancer Res. 63:1743–1747.
   PubMed Web of Science ®Google Scholar
• Liu, Z., Ghai J., Ostrow R. S., McGlennen R. C., and Faras A. J.. 1994. The E6 gene of human papillomavirus type 16 is sufficient for transformation of baby rat kidney cells in cotransfection with activated Ha-ras. Virology 201:388–396.
   PubMedGoogle Scholar
• Lundberg, A. S., Hahn W. C., Gupta P., and Weinberg R. A.. 2000. Genes involved in senescence and immortalization. Curr. Opin. Cell Biol. 12:705–709.
   PubMed Web of Science ®Google Scholar
• Michalovitz, D., Fischer-Fantuzzi L., Vesco C., Pipas J. M., and Oren M.. 1987. Activated Ha-ras can cooperate with defective simian virus 40 in the transformation of nonestablished rat embryo fibroblasts. J. Virol. 61:2648–2654.
   PubMedGoogle Scholar
• Narita, M., Nunez S., Heard E., Narita M., Lin A. W., Hearn S. A., Spector D. L., Hannon G. J., and Lowe S. A.. 2003. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113:703–716.
   PubMed Web of Science ®Google Scholar
• Neufeld, D. S., Ripley S., Henderson A., and Ozer H. L.. 1987. Immortalization of human fibroblasts transformed by origin-defective simian virus 40. Mol. Cell. Biol. 7:2794–2802.
   PubMed Web of Science ®Google Scholar
• Oh, H., Taffet G. E., Youker K. A., Entman M. L., Overbeek P. A., Michael L. H., and Schneider M. D.. 2001. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc. Natl. Acad. Sci. USA 98:10308–10313.
   PubMed Web of Science ®Google Scholar
• Ohtani, N., Zebedee Z., Huot T. J., Stinson J. A., Sugimoto M., Ohashi Y., Sharrocks A. D., Peters G., and Hara E.. 2001. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409:1067–1070.
   PubMed Web of Science ®Google Scholar
• Palmero, I., Pantoja C., and Serrano M.. 1998. p19ARF links the tumour suppressor p53 to Ras. Nature 395:125–126.
   PubMed Web of Science ®Google Scholar
• Passalaris, T. M., Benanti J. A., Gewin L., Kiyono T., and Galloway D. A.. 1999. The G2 checkpoint is maintained by redundant pathways. Mol. Cell. Biol. 19:5872–5881.
   PubMed Web of Science ®Google Scholar
• Phelps, W. C., Yee C. L., Munger K., and Howley P. M.. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539–547.
   PubMed Web of Science ®Google Scholar
• Ramirez, R. D., Morales C. P., Herbert B. S., Rohde J. M., Passons C., Shay J. W., and Wright W. E.. 2001. Putative telomere-independent mechanisms of replicative aging reflect inadequate growth conditions. Genes Dev. 15:398–403.
   PubMed Web of Science ®Google Scholar
• Ruas, M., and Peters G.. 1998. The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta 1378:F115–F177.
   PubMed Web of Science ®Google Scholar
• Ruley, H. E. 1983. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature 304:602–606.
   PubMed Web of Science ®Google Scholar
• Schmitt, C. A., Fridman J. S., Yang M., Lee S., Baranov E., Hoffman R. M., and Lowe S. W.. 2002. A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy. Cell 109:335–346.
   PubMed Web of Science ®Google Scholar
• Seger, Y. R., Garcia-Cao M., Piccinin S., Cunsolo C. L., Doglioni C., Blasco M. A., Hannon G. J., and Maestro R.. 2002. Transformation of normal human cells in the absence of telomerase activation. Cancer Cell 2:401–413.
   PubMed Web of Science ®Google Scholar
• Serrano, M., and Blasco M. A.. 2001. Putting the stress on senescence. Curr. Opin. Cell Biol. 13:748–753.
   PubMed Web of Science ®Google Scholar
• Serrano, M., Lin A. W., McCurrach M. E., Beach D., and Lowe S. W.. 1997. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88:593–602.
   PubMed Web of Science ®Google Scholar
• Smith, L. L., Coller H. A., and Roberts J. M.. 2003. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 5:474–479.
   PubMed Web of Science ®Google Scholar
• Stewart, S. A., Hahn W. C., O'Connor B. F., Banner E. N., Lundberg A. S., Modha P., Mizuno H., Brooks M. W., Fleming M., Zimonjic D. B., Popescu N. C., and Weinberg R. A.. 2002. Telomerase contributes to tumorigenesis by a telomere length-independent mechanism. Proc. Natl. Acad. Sci. USA 99:12606–12611.
   PubMed Web of Science ®Google Scholar
• Voorhoeve, P. M., and Agami R.. 2003. The tumor-suppressive functions of the human INK4A locus. Cancer Cell 4:311–319.
   PubMed Web of Science ®Google Scholar
• Wei, W., Hemmer R. M., and Sedivy J. M.. 2001. Role of p14ARF in replicative and induced senescence of human fibroblasts. Mol. Cell. Biol. 21:6748–6757.
   PubMedGoogle Scholar
• Wei, W., Jobling W. A., Chen W., Hahn W. C., and Sedivy J. M.. 2003. Abolition of cyclin-dependent kinase inhibitor p16Ink4a and p21Cip1/Waf1 functions permits Ras-induced anchorage-independent growth in telomerase-immortalized human fibroblasts. Mol. Cell. Biol. 23:2859–2870.
   PubMed Web of Science ®Google Scholar
• Xu, D., and Finkel T.. 2002. A role for mitochondria as potential regulators of cellular life span. Biochem. Biophys. Res. Commun. 294:245–248.
   PubMed Web of Science ®Google Scholar
• Zhu, J., Woods D., McMahon M., and Bishop J. M.. 1998. Senescence of human fibroblasts induced by oncogenic Raf. Genes Dev. 12:2997–3007.
   PubMed Web of Science ®Google Scholar